Your browser doesn't support javascript.
loading
Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09).
Niegisch, Günter; Retz, Margitta; Thalgott, Mark; Balabanov, Stefan; Honecker, Friedemann; Ohlmann, Carsten Henning; Stöckle, Michael; Bögemann, Martin; Vom Dorp, Frank; Gschwend, Jürgen; Hartmann, Arndt; Ohmann, Christian; Albers, Peter.
Affiliation
  • Niegisch G; Department of Urology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Oncology ; 89(2): 70-8, 2015.
Article in En | MEDLINE | ID: mdl-25765871
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urologic Neoplasms / Paclitaxel / Urothelium / Everolimus / Antineoplastic Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Oncology Year: 2015 Document type: Article Affiliation country: Germany Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urologic Neoplasms / Paclitaxel / Urothelium / Everolimus / Antineoplastic Agents Type of study: Clinical_trials Aspects: Patient_preference Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Oncology Year: 2015 Document type: Article Affiliation country: Germany Country of publication: Switzerland